Athira Pharma Reports Third Quarter 2023 Financial Results a

Continues to report clinical and preclinical findings supporting the potential benefits of its small molecule therapeutic candidates targeting the...

Related Keywords

Washington , United States , Seattle , Julie Rathbun , Sharay Setti , Mark Litton , Athira Pharma , Wei Wu , Facebook , Twitter , Waltere Washington Convention Center , Drug Administration , Development Of Novel Therapies For Neurodegenerative , Society For Neuroscience , Clinical Development Pipeline Programs , Securities Exchange , Nasdaq , Alzheimer Association International Conference , Athira Pharma Inc , Linkedin , Development Rd Expenses , Exchange Commission , Instagram , Chief Executive Officer , Global Statistical Test , Label Extension , Upcoming Presentations , Association International Conference , Annual Clinical Trials , Annual Northeast , Convention Center , Novel Therapies , Senior Scientist , Securities Act , Securities Exchange Act , Private Securities Litigation Reform Act , Consolidated Statements ,